Vertex Pharmaceuticals to Buy Alpine Immune in $4.9B Deal
Vertex Pharma's $4.9 billion takeover of Alpine Immune expected to boost its rare-disease portfolio
Vertex will buy Alpine Immune Sciences for $4.9B in another big Seattle biotech deal
Vertex Pharmaceuticals to acquire Alpine Immune Sciences for $4.9 billion
Vertex Pharmaceuticals to buy Alpine Immune Sciences for $4.9 bln